To validate the pathogenic nature of this mutation, PSEN1 Val97Leu was first expressed in human neuroblastoma (SH‐SY5Y) cells, and the Aβ concentration was monitored with ELISA and radioimmunity methods. The gene discussed is PSEN1; the disease is neuroblastoma.